more general categories
information about this item
03. Biological Effects of Specific Chemicals
03. Biological Effects of Specific Chemicals
ruxolitinib [CHEBI:66919] (1)
05. Industrial Uses
05. Industrial Uses
ruxolitinib [CHEBI:66919] (1)
08. Chemical Category
08. Chemical Category
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ruxolitinib [CHEBI:66919] (1)
ChEBI Compound Accession Identifier :
[CHEBI:66919]
ChEBI Compound Description :
A pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
ChEBI Compound Identification Number :
66919
ChEBI InChI Value :
InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1
ChEBI InChIKey Value :
HFNKQEVNSGCOJV-OAHLLOKOSA-N
ChEBI Compound Name :
ruxolitinib
ChEBI SMILES Value :
N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12
ChEBI Substance ID :
160645455
ChEBI URL :
ChEBI:66919
ChemSpider ID :
25027389
Ontomatica Chemical Accession Key (OnChAKey) :
HFNKQEVNSGCOJV_OAHLLOKOSA_N_000_000000
PubChem Compound ID :
25126798